Use of modafinil for the treatment of attention deficit/hyperactivity disorder

Annals of Pharmacotherapy

Volumn 40, Issue 10, 2006, Pages 1829-1833

  Lindsay, Shane E ^a   Gudelsky, Gary A ^a   Heaton, Pamela C ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b NONE   (United States)

Author keywords

Attention deficit hyperactivity disorder; Modafinil

Indexed keywords

DEXAMPHETAMINE; MODAFINIL; PLACEBO;

ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; COCHRANE LIBRARY; COGNITION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HEADACHE; HUMAN; INSOMNIA; MEDLINE; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; TITRIMETRY; VISUAL ANALOG SCALE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BENZHYDRYL COMPOUNDS; HUMANS;

EID: 33749615712     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H024     Document Type: Review

References (13)

1. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics. Pediatrics 2000;105:1158-70.
2. Facts and Comparisons Online. www.factsandcomparisons.com (accessed 2006 May 30).
3. Schweitzer JB, Holcomb HH. Drugs under investigation for attention-deficit hyperactivity disorder. Curr Opin Investig Drugs 2002;3:1207-11.
4. Kratochvil CJ, Heiligenstein JH, Dittmann R, et al. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry 2002; 41:776-84.
5. Wernicke JF, Kratochvil CJ. Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. J Clin Psychiatry 2002; 63(suppl 12):50-5.
6. Wernicke JF, Faries D, Girod D, et al. Cardiovascular effects of atomoxetine in children, adolescents, and adults. Drug Saf 2003;26:729-40.
7. Swanson JM. Role of executive function in ADHD. J Clin Psychiatry 2003;64(suppl 14):35-9.
8. Myrick H, Malcolm R, Taylor B, LaRowe S. Modafinil: preclinical, clinical, and post-marketing surveillance-a review of abuse liability issues. Ann Clin Psychiatry 2004;16:101-9.
9. Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol 2000;10:311-20.
10. Rugino TA, Samsock TC. Modafinil in children with attention-deficit hyperactivity disorder. Pediatr Neurol 2003;29:136-42.
11. Biederman J, Swanson JM, Wigal SB, et al. Efficacy and safety of modafmil film-coated tablets in children and adolescents with attention-deficit/ hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics 2005;116:e777-84.
12. Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ. Modafinil improves cognition and response inhibition in adult attention-deficit/ hyperactivity disorder. Biol Psychiatry 2004;55:1031-40.
13. FDA panel: modafinil unsae for ADHD use in children, www.ashp.org/news/ showarticle.cfm?id=14656 (accessed 2006 Aug 25).